Your Digital Self: The old reliable laptop is getting a makeover and could be tech’s next new thing

The consumer electronics industry is getting new life from an old product: laptops. Although the changes are evolutionary rather than revolutionary, they’re substantial enough to make the laptop sector more competitive with the desktop PC sector of the market. This is especially significant as global PC sales tumbled 19.5% in the third quarter of 2022 […]

Continue Reading

Financial Crime: After the collapse of FTX, Celsius and Genesis, crypto’s million-dollar question remains: Will customers see any of their money again?

Customers of failed crypto ventures like FTX, Celsius Network or Genesis may one day see some of their money again, but they better be prepared to wait. Experts say recovering money from frauds and other financial collapses is a complex and hard-to-predict process and while often some money can be returned, it can take years […]

Continue Reading

In One Chart: Households earning $100,000 or more are cutting spending more aggressively. What’s going on?

We want to hear from readers who have stories to share about the effects of increasing costs and a changing economy. If you’d like to share your experience, write to readerstories@marketwatch.com. Please include your name and the best way to reach you. A reporter may be in touch. Higher-earning households are feeling the inflationary pinch. Consumer […]

Continue Reading

The Margin: Prince Harry’s ‘Spare’ has sold 629,300 print copies in the U.S., but its first-week sales didn’t top Obama’s ‘A Promised Land’ debut

When it comes to first-week book sales, Prince Harry may be ruling the roost. But former President Barack Obama still has him beat. “Spare,” the newly released tell-all tome by Prince Harry, sold 629,300 print copies in the U.S. during its first week, according to NPD BookScan, the leading tracker of book sales. That made […]

Continue Reading

: One of the greatest cancer drugs ever has suddenly lost its edge. This is why it was vulnerable.

In November, British-Swedish drug giant AstraZeneca published a simple chart in its quarterly earnings presentation that the pharmaceutical industry never saw coming. It showed that 55% of chronic lymphocytic leukemia patients in the U.S. were choosing Calquence, and not Imbruvica, the long-time leading treatment for the disease, when being prescribed a class of drug known […]

Continue Reading

MarketWatch First Take: Netflix co-founder Reed Hastings showed Silicon Valley the proper leadership path

Silicon Valley founders could learn a lot from the orderly, drama-free succession planning at Netflix Inc. that reached a conclusion Thursday. Co-founder Reed Hastings stepped down as co-chief executive Thursday, roughly 25 years after he and co-founder Marc Randolph hatched the idea that ultimately became Netflix NFLX, +8.46% in the dot-com era. They started out […]

Continue Reading